Metropolitan Life Insurance Company (MetLife)’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,212
| Closed | -$62K | – | 2475 |
|
|
2022
Q1 | $62K | Sell |
2,212
-7,706
| -78% | -$211K | ﹤0.01% | 1468 |
|
|
2021
Q4 | $271K | Hold |
9,918
| – | – | ﹤0.01% | 1805 |
|
|
2021
Q3 | $270K | Sell |
9,918
-872
| -8% | -$21.6K | ﹤0.01% | 1862 |
|
|
2021
Q2 | $184K | Buy |
10,790
+1,753
| +19% | +$32.8K | ﹤0.01% | 2205 |
|
|
2021
Q1 | $189K | Sell |
9,037
-772
| -8% | -$17.8K | ﹤0.01% | 2060 |
|
|
2020
Q4 | $225K | Hold |
9,809
| – | – | ﹤0.01% | 1859 |
|
|
2020
Q3 | $160K | Hold |
9,809
| – | – | ﹤0.01% | 1922 |
|
|
2020
Q2 | $133K | Hold |
9,809
| – | – | ﹤0.01% | 2083 |
|
|
2020
Q1 | $116K | Hold |
9,809
| – | – | ﹤0.01% | 1939 |
|
|
2019
Q4 | $244K | Hold |
9,809
| – | – | ﹤0.01% | 1776 |
|
|
2019
Q3 | $167K | Hold |
9,809
| – | – | ﹤0.01% | 2001 |
|
|
2019
Q2 | $223K | Hold |
9,809
| – | – | ﹤0.01% | 1826 |
|
|
2019
Q1 | $315K | Hold |
9,809
| – | – | 0.01% | 1598 |
|
|
2018
Q4 | $276K | Hold |
9,809
| – | – | 0.01% | 1602 |
|
|
2018
Q3 | $282K | Hold |
9,809
| – | – | ﹤0.01% | 1758 |
|
|
2018
Q2 | $367K | Buy |
9,809
+1,028
| +12% | +$40.4K | 0.01% | 1531 |
|
|
2018
Q1 | $345K | Hold |
8,781
| – | – | ﹤0.01% | 1515 |
|
|
2017
Q4 | $285K | Sell |
8,781
-24,965
| -74% | -$749K | ﹤0.01% | 1656 |
|
|
2017
Q3 | $1.05M | Buy |
33,746
+16,873
| +100% | +$499K | 0.01% | 1219 |
|
|
2017
Q2 | $472K | Sell |
16,873
-1,074
| -6% | -$24.3K | ﹤0.01% | 1735 |
|
|
2017
Q1 | $308K | Hold |
17,947
| – | – | ﹤0.01% | 1983 |
|
|
2016
Q4 | $217K | Hold |
17,947
| – | – | ﹤0.01% | 2309 |
|
|
2016
Q3 | $284K | Hold |
17,947
| – | – | ﹤0.01% | 2102 |
|
|
2016
Q2 | $232K | Buy |
17,947
+2,869
| +19% | +$44.9K | ﹤0.01% | 2217 |
|
|
2016
Q1 | $286K | Buy |
15,078
+4,629
| +44% | +$83.9K | ﹤0.01% | 1931 |
|
|
2015
Q4 | $235K | Hold |
10,449
| – | – | ﹤0.01% | 2141 |
|
|
2015
Q3 | $245K | Hold |
10,449
| – | – | ﹤0.01% | 2138 |
|
|
2015
Q2 | $299K | Buy |
+10,449
| New | +$274K | ﹤0.01% | 2122 |
|
Metropolitan Life Insurance Company (MetLife)'s XENT Position: Q2 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 2,212 shares — an estimated $62K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in XENT in Q2 2015 and held it in 28 quarters. The position peaked at $1.05M in Q3 2017. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,212 Intersect ENT, Inc shares in Q2 2022, an estimated $62K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 28 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Intersect ENT, Inc position peaked at $1.05M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.